Omnicell, Inc.
OMCLNASDAQHealthcareHealth Information Services
As of Oct 16, 2026 close
- Market cap
- $1.66B
- P/E (TTM)
- 42.59
- Forward P/E
- 24.87
- Dividend yield
- -
- 52-week range
- $29.06$55.00
- Volume (live)
- -
- Avg. volume (3M)
- 505.59K
Omnicell (OMCL) Stock Price & Financial Analysis
Omnicell Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $35.08 - $36.52 |
|---|---|
| 52-Week High | $55.00 |
| 52-Week Low | $29.06 |
| Open | $36.12 |
| Volume (last close) | 426.65K |
| Average Volume (3M) | 505.59K |
| Revenue (TTM) | 1.25B |
|---|---|
| Net Income (TTM) | 39.08M |
| Free Cash Flow (TTM) | 135.64M |
| EPS (TTM) | $0.85 |
| Profit Margin | 3.13% |
| Operating Margin | 4.73% |
| Return on Equity (ROE) | 3.03% |
| Debt to Equity | 0.14 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.66B |
|---|---|
| Shares Outstanding | 46.30M |
| P/E Ratio (TTM) | 42.59 |
| Forward P/E | 24.87 |
| Price to Sales (P/S) | 1.34 |
| Price to Book (P/B) | 1.29 |
| EV/EBITDA | 15.78 |
| 50-Day MA | $34.65 |
|---|---|
| 200-Day MA | $39.74 |
| 1-Year Change | +20.23% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Omnicell at a Glance
As of the Oct 16, 2026 close, Omnicell (OMCL) has a market capitalization of $1.66B. The stock trades at 42.6× trailing earnings, 24.9× forward earnings and 1.3× sales. Over the trailing twelve months it earned $39.08M on revenue of $1.25B (a 3.1% profit margin) and generated $135.64M of free cash flow. Revenue grew 8.4% year over year.
As of its latest reported balance sheet, it holds $292.17M in cash and securities against $179.69M of debt, a net cash position of $112.48M.
Omnicell does not currently pay a dividend.
The share price is up 20.2% over the past year. At $35.39 (the Oct 16, 2026 close) it sits within its 52-week range of $29.06 to $55.00, below its 200-day moving average of $39.74.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $56.00, 58.2% above the Oct 16, 2026 close.
Frequently Asked Questions About Omnicell
What is the current stock price for OMCL?
As of the Oct 16, 2026 close, OMCL stock trades at $35.39. The 52-week range is $29.06–$55.00, with a day range of $35.08–$36.52.
What is the P/E ratio for OMCL?
As of the Oct 16, 2026 close, Omnicell's trailing twelve-month (TTM) P/E ratio is 42.6, meaning investors pay $42.6 for every $1 of annual earnings. The forward P/E is 24.9, reflecting analyst expectations for future earnings. Omnicell operates in the Healthcare sector.
Does OMCL pay dividends?
Omnicell does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for OMCL?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for OMCL is Buy. The average 12-month price target is $56.00, a 58.2% upside from the Oct 16, 2026 close of $35.39.
What is the market cap of OMCL?
As of the Oct 16, 2026 close, Omnicell's market capitalization is $1.64B, classifying it as a small-cap company. Omnicell operates in the Healthcare sector within the Health Information Services industry.